Integra LifeSciences Holdings Corporation (IART)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-09-29. ClinicalTrials.gov
Dilution Risk
MEDIUM DILUTION RISKDilution score: 26/100 (MEDIUM), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 11.6% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
- Why Integra LifeSciences (IART) Stock Is Nosediving
- Sector Update: Healthcare Stocks Steady Late Afternoon
- Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B
- IART vs. PEN: Which Stock Is the Better Value Option?
- IART or PEN: Which Is the Better Value Stock Right Now?
- Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry
- Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Thirty-day outcomes following transcarotid artery revascularization with integrated embolic protection: The PERFORMANCE III study. — J Vasc Surg 2026 Oct PMID 42203082
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Integra LifeSciences Holdings Corporation.
Full IART Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.